Bajaj Healthcare said that it has received approval from the Drug Controller General of India (DCGI) to manufacture both the API and drug formulation of Pimavanserin.
The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback